Cargando…
PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts
Esophageal cancer is one of the least studied and deadliest cancers worldwide with a poor prognosis due to limited options for treatment. Chemotherapy agents such as the microtubule-targeting compounds are the mainstay of palliation for advanced esophageal cancer treatment. However, the toxicity and...
Autores principales: | Sheng, Yuqiao, Liu, Kangdong, Wu, Qiong, Oi, Naomi, Chen, Hanyong, Reddy, Kanamata, Jiang, Yanan, Yao, Ke, Li, Haitao, Li, Wei, Zhang, Yi, Saleem, Mohammad, Ma, Wei-Ya, Bode, Ann M., Dong, Ziming, Dong, Zigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058732/ https://www.ncbi.nlm.nih.gov/pubmed/27129160 http://dx.doi.org/10.18632/oncotarget.9050 |
Ejemplares similares
-
APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model
por: Jin, Guoguo, et al.
Publicado: (2017) -
244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells
por: Zhang, Yi, et al.
Publicado: (2015) -
Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance()()()
por: Li, Haitao, et al.
Publicado: (2014) -
HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E
por: Chang, Xiaoyu, et al.
Publicado: (2020) -
Targeting integrin αvβ3 with indomethacin inhibits patient‐derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma
por: Liu, Fangfang, et al.
Publicado: (2021)